Natixis Advisors LLC reduced its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 26.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 48,634 shares of the technology company’s stock after selling 17,521 shares during the period. Natixis Advisors LLC’s holdings in Veeva Systems were worth $10,857,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the company. AXQ Capital LP purchased a new stake in shares of Veeva Systems during the 4th quarter worth $910,000. Root Financial Partners LLC lifted its position in shares of Veeva Systems by 17.1% during the 4th quarter. Root Financial Partners LLC now owns 383 shares of the technology company’s stock worth $85,000 after buying an additional 56 shares during the last quarter. BNP Paribas lifted its position in shares of Veeva Systems by 89.3% during the 4th quarter. BNP Paribas now owns 19,239 shares of the technology company’s stock worth $4,308,000 after buying an additional 9,077 shares during the last quarter. Arcadia Investment Management Corp MI lifted its position in shares of Veeva Systems by 1.1% during the 4th quarter. Arcadia Investment Management Corp MI now owns 43,214 shares of the technology company’s stock worth $9,647,000 after buying an additional 460 shares during the last quarter. Finally, Main Management ETF Advisors LLC lifted its position in shares of Veeva Systems by 1.0% during the 4th quarter. Main Management ETF Advisors LLC now owns 5,481 shares of the technology company’s stock worth $1,224,000 after buying an additional 56 shares during the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.
More Veeva Systems News
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva beat Q1 earnings and revenue estimates, with EPS of $2.24 and revenue of $882.9 million, while also raising its fiscal 2027 outlook. Veeva Systems beats estimates on AI progress
- Positive Sentiment: Management highlighted AI momentum, including Falcon AI agents, CRM migration wins, and the Ostro acquisition, suggesting new growth drivers beyond the core platform. Veeva Systems Q1 Earnings Call Highlights AI Push & Higher Outlook
- Positive Sentiment: Several brokers remained constructive, including Barclays, Oppenheimer, RBC, Needham, BTIG, and Robert W. Baird, many of which kept buy/outperform ratings and elevated price targets. Veeva Systems (VEEV) Receives a Buy from Barclays
- Neutral Sentiment: Citigroup raised its target to $190 and maintained a neutral stance, while UBS and Canaccord also trimmed targets but stayed at neutral/hold, reflecting a more mixed Street view. Analyst updates
- Negative Sentiment: Despite the beat-and-raise quarter, the stock sold off as investors likely questioned how much of the AI optimism is already priced in and whether legacy CRM migration dynamics could pressure growth. Is Veeva Stock Undervalued At $170?
- Negative Sentiment: Goldman Sachs cut its price target to $165 and kept a sell rating, adding to the cautious tone around the name. Veeva Systems price target lowered by Goldman Sachs
Insider Activity at Veeva Systems
Veeva Systems Price Performance
Shares of VEEV opened at $172.96 on Friday. Veeva Systems Inc. has a 1-year low of $148.05 and a 1-year high of $310.50. The stock has a market cap of $28.25 billion, a PE ratio of 30.83, a price-to-earnings-growth ratio of 0.76 and a beta of 0.95. The firm has a fifty day moving average price of $166.17 and a 200 day moving average price of $195.74.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.89%. The firm had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. During the same period in the previous year, the company earned $1.97 earnings per share. Veeva Systems’s quarterly revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, equities analysts expect that Veeva Systems Inc. will post 6.46 EPS for the current fiscal year.
Analysts Set New Price Targets
Several analysts have recently weighed in on the stock. BTIG Research restated a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research report on Thursday. Citigroup boosted their price target on shares of Veeva Systems from $176.00 to $190.00 and gave the company a “neutral” rating in a research report on Thursday. Evercore reissued an “outperform” rating and issued a $185.00 price target on shares of Veeva Systems in a research report on Thursday. The Goldman Sachs Group reduced their price target on shares of Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a research report on Thursday. Finally, Canaccord Genuity Group reduced their price target on shares of Veeva Systems from $235.00 to $220.00 and set a “hold” rating for the company in a research report on Thursday. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Veeva Systems currently has an average rating of “Moderate Buy” and a consensus price target of $250.96.
View Our Latest Report on Veeva Systems
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Recommended Stories
- Five stocks we like better than Veeva Systems
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
